These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7247990)

  • 21. Abnormal regulation of the LDL-R and HMG CoA reductase genes in subjects with familial hypercholesterolemia with the "French Canadian mutation".
    Yu L; Qiu S; Genest J
    Atherosclerosis; 1996 Jul; 124(1):103-17. PubMed ID: 8800498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of lipids and endothelial and smooth muscle cells of umbilical cord in familial homozygous hypercholesterolemia.
    Ostlund RE; Hajek SV; Levy RA; Witztum JL
    Metabolism; 1981 Mar; 30(3):285-9. PubMed ID: 7207202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetics of the low density lipoprotein receptor: I. Low density lipoprotein receptor activity in cultured fibroblasts from subjects with or without familial hypercholesterolemia.
    Maartmann-Moe K; Berg-Johnsen P
    Clin Genet; 1981 Aug; 20(2):90-103. PubMed ID: 6273032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemia.
    Gianturco SH; Gotto AM; Jackson RL; Patsch JR; Sybers HD; Taunton OD; Yeshurun DL; Smith LC
    J Clin Invest; 1978 Feb; 61(2):320-8. PubMed ID: 202612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diversity in expression of heterozygous familial hypercholesterolemia. Characterization of a unique kindred.
    Levy RA; Ostlund RE; Semenkovich CF; Witztum JL
    J Clin Invest; 1986 Jul; 78(1):96-101. PubMed ID: 3722389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss-of-function mutation R46L in the PCSK9 gene has little impact on the levels of total serum cholesterol in familial hypercholesterolemia heterozygotes.
    Strøm TB; Holla ØL; Cameron J; Berge KE; Leren TP
    Clin Chim Acta; 2010 Feb; 411(3-4):229-33. PubMed ID: 19917273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and the esterification of cholesterol in human long term lymphoid cell lines.
    Kayden HJ; Hatam L; Beratis NG
    Biochemistry; 1976 Feb; 15(3):521-8. PubMed ID: 1252410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man.
    Krempler F; Kostner GM; Roscher A; Haslauer F; Bolzano K; Sandhofer F
    J Clin Invest; 1983 May; 71(5):1431-41. PubMed ID: 6304146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The longest-lived patient with homozygous familial hypercholesterolemia secondary to a defect in internalization of the LDL receptor.
    Komuro I; Kato H; Nakagawa T; Takahashi K; Mimori A; Takeuchi F; Nishida Y; Miyamoto T
    Am J Med Sci; 1987 Nov; 294(5):341-5. PubMed ID: 3425583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of atorvastatin on serum lipids and lipoproteins in patients with homozyous familial hypercholesterolemia undergoing LDL-apheresis therapy.
    Yamamoto A; Harada-Shiba M; Kawaguchi A; Oi K; Kubo H; Sakai S; Mikami Y; Imai T; Ito T; Kato H; Endo M; Sato I; Suzuki Y; Hori H
    Atherosclerosis; 2000 Nov; 153(1):89-98. PubMed ID: 11058703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of ML-236b (compactin) on sterol synthesis and low density lipoprotein receptor activities in fibroblasts of patients with homozygous familial hypercholesterolemia.
    Haba T; Mabuchi H; Yoshimura A; Watanabe A; Wakasugi T; Tatami R; Ueda K; Ueda R; Kametani T; Koizumi J; Miyamoto S; Takeda R; Takeshita H
    J Clin Invest; 1981 May; 67(5):1532-40. PubMed ID: 7229037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presentation of the Kober Medal to Joseph L. Goldstein and Michael S. Brown.
    Foster DW; Wilson JD
    J Clin Invest; 2002 Dec; 110(12):S5-9. PubMed ID: 12506882
    [No Abstract]   [Full Text] [Related]  

  • 33. Familial hypercholesterolemia: mechanism of inheritance.
    de Oya M; Nuno J; Azpeitia AG; Villasante JG
    Diabete Metab; 1980 Sep; 6(3):181-8. PubMed ID: 7439491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population.
    Assouline L; Levy E; Feoli-Fonseca JC; Godbout C; Lambert M
    Pediatrics; 1995 Aug; 96(2 Pt 1):239-46. PubMed ID: 7630677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-saturable degradation of LDL by monocyte-derived macrophages leads to a reduction in HMG-CoA reductase activity with little synthesis of cholesteryl esters.
    Knight BL; Soutar AK; Patel DD
    Atherosclerosis; 1987 Apr; 64(2-3):131-8. PubMed ID: 3606710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The regulation of cholesterol synthesis in human cells.
    Galton DJ
    Int J Obes; 1981; 5(6):619-25. PubMed ID: 6172394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Squalene and noncholesterol sterols in serum and lipoproteins of children with and without familial hypercholesterolemia.
    Ketomäki A; Gylling H; Siimes MA; Vuorio A; Miettinen TA
    Pediatr Res; 2003 Apr; 53(4):648-53. PubMed ID: 12612218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulatin of phospholipid and cholesterol ester synthesis by platelet-derived growth factor in normal and homozygous familial hypercholesterolemia human skin fibroblasts.
    Leslie CC; Antoniades HN; Geyer RP
    Biochim Biophys Acta; 1982 May; 711(2):290-304. PubMed ID: 7093297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic cholesterol synthesis in patients with familial hypercholesterolemia (FHC) proven by fibroblast culture.
    Zöllner N; Keller C; Wieczorek A
    Atherosclerosis; 1980 Dec; 37(4):647-9. PubMed ID: 7459009
    [No Abstract]   [Full Text] [Related]  

  • 40. Homozygous familial hypercholesterolemia mutant with a defect in internalization of low density lipoprotein.
    Miyake Y; Tajima S; Yamamura T; Yamamoto A
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5151-5. PubMed ID: 6272292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.